闵军霞医学院 | 浙江大学转化医学研究院基础医学· 肿瘤的转化医学研究· 人类衰老与长寿的转化医学研究· CAR-T的全程优化研究个人简介:闵军霞 浙江大学转化医学研究院 浙江大学医学院附属第一医院   教授，博士生导师2006年获得美国密苏里哥伦比亚大学肿瘤生物学博士。2006-2010年在哈佛大学医学院医学遗传系任博士后。2010-2014年任诺华（Novartis，美国）肿瘤部新药研发团队负责人，主要负责整合分析多种组学大数据，发现肿瘤新型分子靶标及CAR-T的优化研究。2014年，加盟浙江大学并入选浙江省海外高层次“浙江省千人”创新学者及“浙江省特聘专家”。主要研究方向：以中国高发肿瘤的病人基因组学大数据为出发点，探 索适用于中国肿瘤病人基因型的有效新型靶向治疗、免疫治疗及克服 靶向耐药的综合治疗策略。 (1) 主要成就：多年来在美国从事肿瘤转化医学研究，在国际上首先发现 鞘氨醇-1-磷酸醇（S1P）代谢通路与肿瘤化疗药物抗性关联及作用靶 点；通过运用多种生物模型，系统性阐明了癌基因EZH2通过抑制抑癌 基因DAB2IP，进而激活Ras和NF-kappa B致癌通路诱发并促使肿瘤转移 的新机制，为前列腺癌诊治提供了新策略；成功领导8个肿瘤新药研 发项目，研究并建立了可预测癌症化合物敏感性和预测驱动基因及通 路的新型驱动网络模型;参与领导新型个体化免疫治疗，如CART19治 疗B细胞恶性肿瘤。在国际著名杂志包括Nature Medicine、PNAS、MolecularCancer Research等发表数篇原创性论文。多次受邀在国内外做大会学术报告。先后获得包括诺华科技创新奖、诺华肿瘤药物研发最佳业绩奖等一系列奖项。 (2) 获得的重要奖项 :2015年长三角绿色制药协同创新中心“特聘研究员";  2014年浙江省海外高层次人才引进计划浙江省特聘专家; 2013 年诺华优秀课题负责人奖;  2012 年诺华优秀课题负责人奖;  2012 年荣获诺华科技创新奖;  2011 年诺华肿瘤药物研发最佳业绩奖;  2006 年美国密苏里哥伦比亚大学优秀研究一等奖 目前主要研究方向：1. CAR-T的全程优化研究；2. 肿瘤的转化医学研究；3.人类衰老与长寿的转化v医学研究实验室地址：杭州市江干区凯旋路268号 浙江大学华家池校区中心大楼北楼 203室课题组招聘启事教学与课程:教学课程研究生科研技能训练Ⅰ （科研文献阅读与科研论文写作）硕博生课肿瘤研究前沿      博士生课研究与成果:代表性论文通讯作者论文1.Zhao X# Liu X# Zhang A# Chen H# Huo Q Li W Ye R Chen Z Liang L Liu QA Shen J Jin X Li W Nygaard M Liu X Hou Y Ni T Bolund L Gottschalk W Tao W Gu J Tian XL Yang H Wang J Xu X Lutz MW Min J* Zeng Y* Nie C*. The correlation of copy number variations with longevity in a genome-wide association study of Han Chinese. Aging (Albany NY). 2018 Jun 5.2.Fang X# Wei J# He X# Lian J# Han D An P Zhou T Liu S Wang F* Min J*. Quantitative association between body mass index and the risk of cancer: A global Meta-analysis of prospective cohort studies. International Journal of Cancer. 2018 Apr 26.3.An P Wang H Wu Q Wang J Xia Z He X Wang X Chen Y Min J* Wang F*. Smad7 deficiency decreases iron and haemoglobin through hepcidin up-regulation by multilayer compensatory mechanisms. Journal of Cellular and Molecular Medicine 2018 Mar 30. 4.Zhang Y# Wang X# Wu Q Wang H Zhao L Wang X Mu M Xie E He X Shao D Shang Y Lai Y Ginzburg Y Min J* and Wang F*. Adenine alleviates iron overload by cAMP/PKA mediated hepatic hepcidin in mice. Journal of Cellular Physiology 2018 Mar 30. 5.Gao H Zhao L Wang H Xie E Wang X Wu Q Yu Y He X Ji H Rink L Min J Wang F. Metal transporter Slc39a10 regulates susceptibility to inflammatory stimuli by controlling macrophage survival. PNAS. 2017 Dec 5;114(49):12940-12945. Epub 2017 Nov 26.Wang H An P Xie E Wu Q Fang X Gao H Zhang Z Li Y Wang X Zhang J Li G Yang L Liu W Min J* Wang F*. Characterization of Ferroptosis in Murine Models of Hemochromatosis. Hepatology 2017 Aug;66(2):449-465. Epub 2017 May 162017.7.HDAC1 Governs Iron Homeostasis Independent of Histone Deacetylation in Iron-overload Murine Models. Yin X Wu Q Monga J Xie   E Wang H Wang S Zhang H Wang ZY Zhou T Shi Y Rogers J Lin H Min J* Wang F*. Antioxidants & Redox Signaling. 2017 Nov 7. 8.Wu Q Shen Y Tao Y Wei J Wang H An P Zhang Z Gao H Zhou T Wang F* Min J*. Hemojuvelin regulates the innate immune response to peritoneal bacterial infection in mice. Cell Discovery. 2017 Aug 15; 3:17028. doi: 10.1038/celldisc.2017.28. 9.Xia Z Wei J Li Y Wang J Li W Wang K Hong X Zhao L Chen C Min J* Wang F*. Zebrafish slc30a10 deficiency revealed a novel compensatory mechanism of Atp2c1 in maintaining manganese homeostasis. PLOS Genetics. 2017 Jul 10;13(7): e1006892.doi: 10.1371/journal.pgen.1006892.10.Wang X# An P# Zeng J Liu X Wang B Fang X Wang F* Ren G* Min J*. Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer. Oncotarget 2017. doi:10.18632/oncotarget.1497711.Fang X Wei J He X An P Wang H Jiang L Shao D Liang H Li Y Wang F* Min J*. Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies. European Journal of Cancer. 2015; 51:2820–2832.12.An P Wang H Wu Q Guo X Wu A Zhang Z Zhang D Xu X Mao Q Shen X Zhang L Xiong Z He L Liu Y Min J* Zhou D* Wang F*. Elevated serum transaminase activities were associated with increased serum levels of iron regulatory hormone hepcidin and hyperferritinemia risk. Scientific Reports. 2015; 5:13106.13. Wu Q Wang H An P Tao Y Deng J Zhang Z Shen Y Min J* Wang F*. HJV and HFE Play Distinct Roles in Regulating Hepcidin. Antioxidants & Redox Signaling. 2015;22(15):1325-36. 第一作者论文1.Min J Fedele G Zaslavsky A Reczek E Guney I Strochlic D Bronson RT Hahn WC Ryeom S Loda M and Cichowski K. (2010) An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and NF-kB. Nature Medicine Mar;16(3):286-94 (Article)2.Min J Mesika A Sivaguru M Van Veldhoven PP Alexander H Anthony H. Futerman AH and Alexander S. (2007) LASS1 dihydroceramide synthase induced sensitivity to cisplatin is mediated through the activation of p38 MAP kinase and is abrogated by sphingosine kinase 1. Molecular Cancer Research. 5(8):801-12 (Cover article)3.Min J. Sridetive P. Hanigan MH. Alexander H. (2006) Sensitive cell viability assay for use in drug screens and for studying the mechanism of action of drugs in Dictyosteliumdiscoideum. Biotechniques 41(5):591-5. (Featured article)4.Min J. Van Veldhoven PP Zhang L Hanigan MH Alexander H Alexander S. (2005) Sphingosine-1-Phosphate Lyase Regulates Sensitivity of Human Cells to Select Chemotherapy Drugs in a p38-Dependent Manner. Molecular Cancer Research3:287-296. 5.Min J. Traynor D. Stegner A.L Zhang L. Hanigan M.H. Alexander H. and Alexander S. (2005) Sphingosine kinase regulates the sensitivity of Dictyostelium Discoideum cells to the anticancer drug cisplatin. Eukaryotic Cell 4:178-1896.Min J Stegner A.L Alexander H. and Alexander S. (2004) Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum based chemotherapy drugs. Eukaryotic Cell 3:795-8057.Jaeger S# Min J# Nigsch F Camargo M Hutz J Cornett A Cleaver S Buckler A Jenkins J. L. Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer. Journal of Biomolecular Screening. 2014;19(5):791-802.8.Zeng Y# Nie C# Min J# Liu X# Li M Chen H Xu H Wang M Ni T Li Y Yan H Zhang JP Song C Chi LQ Wang HM Dong J Zheng GY Lin L Qian F Qi Y Liu X Cao H Wang Y Zhang L Li Z Zhou Y Wang Y Lu J Li J Qi M Bolund L Yashin A Land KC Gregory S Yang Z Gottschalk W Tao W Wang J Wang J Xu X Bae H Nygaard M Christiansen L Christensen K Franceschi C Lutz MW Gu J Tan Q Perls T Sebastiani P Deelen J Slagboom E Hauser E Xu H Tian XL Yang H Vaupel JW. Novel loci and pathways significantly associated with longevity. Scientific Reports 2016; 6:21243. 合作作者论文1.Manganese transporter Slc39a14 deficiency revealed its key role in maintaining manganese homeostasis in mice. Xin Y Gao H Wang J Qiang Y Imam MU Li Y Wang J Zhang R Zhang H Yu Y Wang H Luo H Shi C Xu Y Hojyo S Fukada T Min J Wang F. Cell Discovery. 2017 Jul 18; 3:17025. doi: 10.1038/celldisc.2017.25.2.Dietary intake of heme iron and body iron status are associated with the risk of gestational diabetes mellitus: a systematic review and meta-analysis. Zhao L Lian J Tian J Shen Y Ping Z Fang X Min J Wang F. Asia Pac J Clin Nutr. 2017;26(6):1092-1106. doi: 10.6133/apjcn.022017.09.3.An P Jiang L Guan Y Wang H Wang J Tian Y Yang W Shi Y Xue J Min J Wang F*. Identification of hereditary hemochromatosis pedigrees and a novel SLC40A1 mutation in Chinese population. Blood Cells Molecules and Diseases. 2017 63:34-36.4.Fang X Wang K Han D He X Wei J Zhao L Imam MU Ping Z Li Y Xu Y Min J Wang F*. Dietary magnesium intake and the risk of cardiovascular disease type 2 diabetes and all-cause mortality: a dose–response meta-analysis of prospective cohort studies. BMC Medicine 2016 14 210.5.Zeng Y Chen H Ni T Ruan R Nie C Liu X Feng L Zhang F Lu J Li J Li Y Tao W Gregory SG Gottschalk W Lutz MW Land KC Yashin A Tan Q Yang Z Bolund L Ming Q Yang H Min J Willcox DC Willcox BJ Gu J Hauser E Tian XL Vaupel JW. Interaction Between the FOXO1A-209 Genotype and Tea Drinking Is Significantly Associated with Reduced Mortality at Advanced Ages. Rejuvenation Research. 2016; 19(3):195-203.6.Fang X Wang H An P Min J and Wang F*. Cardiomyocyte-specific deletion of ferroportin using MCK-Cre has no apparent effect on either cardiac iron homeostasis. International Journal of Cardiology 2015 Dec 15;201:90-2. 7.Mu M An P Shen X Wu Qian Shao D Wang H Zhang Y Zhang S Yao H Min J Wang F*. The dietary flavonoid myricetin regulates iron homeostasis by suppressing hepcidin expression. Journal of Nutritional Biochemistry. 2015;10.015. 8.Zhou Q. Derti A. Ruddy D. Rakiec D. Kao I. Lira M Gibaja V Chan H Yang Y Min J Schlabach M Stegmeier F. A chemical genetics approach for the functional assessment of novel cancer genes. Cancer Research. 2015 May 15;75(10):1949-58. 9.Fang X An P Wang H Wang X Shen X Li X Min J Liu S and Wang F. Dietary intake of heme iron and risk of cardiovascular disease: a dose-response meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis 2015; 25(1): 24-35.10.Huang T# Lan L# Fang X An P Min J Wang F*. Promises and Challenges of Big Data Computing in Health Sciences. Big Data Research 2015 2–11.  11.Wang Y Lee YM Baitsch L Huang A Xiang Y Tong H Lako A Von T Choi C Lim E Min J Li L Stegmeier F Schlegel R Eck MJ Gray NS Mitchison TJ Zhao J. MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. eLife.2014; e01763.12.Sridevi P Alexander H Laviad EL Min J Mesika A Hannink M Futerman AH Alexander S. (2010) Stress-induced ER to Golgi translocation of ceramide synthase 1 is dependent on proteasomal processing. Exp Cell Res. 316(1):78-91.13.Driessche NV Alexander H Min J Kuspa A Alexander S and Shaulsky G. (2007) Global Transcriptional Responses to Cisplatin in Dictyostelium discoideum Identify Potential Drug Targets. PNAS 104(39):15406-11课题组成员:课题组成员研究组组长闵军霞教授 课题组组长               junxiamin@zju.edu.cn  副教授                                                           安鹏                              副教授anpeng86@qq.com博士后                                                           张亦然                              Jitender Monga博士后（已出站）博士后（已出站）zhangyiran_ouc@126.com0015931@zju.edu.cn博士后                                                           李瑾                              詹伟华博士后博士后lijin_12385@sohu .com___867839532@qq.com博士生                                                                                               李广宇                            杨翔 2014级博士生2015博士生andrewmp3@126.comyoungfly521@163.com                                                                                                   王红晓                            谢恩军2016级博士生     2018级博士生hongxiao87@126.com   983777189@qq.com                                                                                           宋秭君                    2017级直博生xtlyszj@zju.edu.cn硕士生                                                                                             李文文                              母庆典2016级硕士生2017级硕士生 347491383@qq.comqingdian0530@163 .com                                                                                            汤碧瑶                     2018级硕士生Tang_biyao@163.com实验室介绍:实验室介绍    以中国高发肿瘤的病人基因组学数据为出发点，团队以自主研发的新型生物信息驱动网络技术，结合基因敲除小鼠及肿瘤病人裸鼠模型等先进技术平台开展肿瘤转化医学研究探索适用于中国肿瘤病人基因型的有效的、新型靶向治疗及免疫学治疗、克服耐药性的综合治疗策略。主要研究方向：1）肿瘤与生物大数据挖掘；2）中国高发消化道肿瘤的靶向治疗及免疫治疗新策略；3）金属代谢与肿瘤发生分子机制主要研究手段：免疫学、肿瘤生物学、分子生物学、生物信息学、医学、遗传学等学科领域相关技术工作研究项目:实验室承担课题项目：1.  国家自然科学基金面上项目，RNA解旋酶DDX17与p53抑癌基因突变的协同作用及分子机制研究，项目批准号：31570791，2016/01-2019/12，84万元，主持。2.  国家自然科学基金重大项目（应对老龄社会的基础科学问题研究课题二）“健康老龄化--老年人口健康影响因素及有效干预的基础科学问题研究”项目批准号: 71490732 2015年1月-2019年12月; 425万；课题组副组长。3.  国家自然科学基金重大研究计划，肝脏树突状细胞在移植肝区域免疫中的作用及研究机制，项目批准号：91542205，2016/01-2020/12，280万元，课题骨干。4.  浙江省自然科学基金重点项目，项目批准号：Z15H160009，胃癌中靶向ERBB3 抑癌效应及分子机制研究，2015/01-2018/12，30万元，主持5.  浙江大学横向课题，人类衰老与长寿的转化医学研究，107万，项目负责人。学术交流:学术交流/讲座报告2015年8月6日-8日:2015中国器官移植大会暨第二届中国器官移植医师年会 特邀大会报告：基于大数据的免疫细胞干预在器官移植中的转化医学研究(中国武汉) 2015年5月22-23日:International Conference on Interdisciplinary Research on Long-term Care and Healthy Aging 特邀大会报告：Hallmarks of Interconnected Aging with Cancer(中国杭州) 2014 年11 月30 日-12 月5 日:第七届亚洲无机化学会议The 7th AsBIC7 Conference 特邀大会报告：Roadmap of Deregulated Iron Metabolic Pathways in Cancer 2014 年6 月22-23 日:第五届中美转化医学年会The 5th Sino-American Symposium on Clinical and Translational Medicine (中国北京) 特邀大会报告：Translational Medicine at the Zhejiang University 2014 年6 月20-21 日:第四届癌症系统生物学国际研讨会 The Fourth International Workshop on Cancer Systems Biology (ICSB 2014) (中国吉林) 特邀大会报告：The power of network analysis in discovering novel cancer therapeutics 2014 年3 月09-14 日:Keystone Symposia: Inflammation Infection and Cancer joint with the conference on Immune Evolution in Cancer （加拿大） Poster presentation “Identification of Tumor-Specific Splicing Isoforms in TCGA” 2013 年4 月21- 26 日:Gordon Research Conference Cancer Genetics and Epigenetics (意大利) Poster presentation “DNA methylation analysis of triple-negative breast cancer” 2008 年5 月27-29 日:Harvard Medical School Genetics Department Retreat (美国) 大会报告 “Identifying a novel oncogenes-tumor suppressor pathway in cancer metastasis”2008 年1 月11 日:MIT & DF/HCC Ludwig Center Retreat (美国) Poster presentation “A novel tumor suppressor in prostate cancer tumorigenesis & metastasis” 2007 年10 月10-12 日:Colrain 20th Anniversary Meeting (美国) 大会报告“A novel tumor suppressor in prostate cancer tumorigenesis & metastasis” 2005 年4 月:EB Annual Meeting San Diego CA （美国） Poster Presentation “Sphingosine-1-phosphate metabolic enzymes affect the cellular response to chemotherapeutic drugs in a p38 dependent manner”奖励荣誉:奖励与荣誉2015年长三角绿色制药协同创新中心“特聘研究员";2014年浙江省海外高层次人才引进计划浙江省特聘专家; 2013 年诺华优秀课题负责人奖;2012 年诺华优秀课题负责人奖;  2012 年荣获诺华科技创新奖;  2011 年诺华肿瘤药物研发最佳业绩奖;  2006 年美国密苏里哥伦比亚大学优秀研究一等奖 